{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "epsTrailingTwelveMonths": -3.76, "epsForward": -2.69, "epsCurrentYear": -2.49, "priceEpsCurrentYear": -0.735743, "sharesOutstanding": 88660496, "bookValue": 0.998, "fiftyDayAverage": 4.40272, "fiftyDayAverageChange": -2.57072, "fiftyDayAverageChangePercent": -0.5838936, "twoHundredDayAverage": 7.229005, "twoHundredDayAverageChange": -5.397005, "twoHundredDayAverageChangePercent": -0.7465765, "marketCap": 162426032, "forwardPE": -0.6810409, "priceToBook": 1.8356713, "sourceInterval": 15, "exchangeDataDelayedBy": 15, "averageAnalystRating": "3.5 - Hold", "tradeable": false, "cryptoTradeable": false, "currency": "NOK", "financialCurrency": "NOK", "regularMarketOpen": 1.95, "averageDailyVolume3Month": 276607, "averageDailyVolume10Day": 272700, "fiftyTwoWeekLowChange": 0.13199997, "fiftyTwoWeekLowChangePercent": 0.07764704, "fiftyTwoWeekRange": "1.7 - 17.01", "fiftyTwoWeekHighChange": -15.178, "fiftyTwoWeekHighChangePercent": -0.89229864, "fiftyTwoWeekLow": 1.7, "fiftyTwoWeekHigh": 17.01, "earningsTimestamp": 1684990800, "earningsTimestampStart": 1684990800, "earningsTimestampEnd": 1684990800, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "firstTradeDateMilliseconds": 1491548400000, "priceHint": 4, "marketState": "REGULAR", "regularMarketChange": -0.110000014, "regularMarketTime": 1684140712, "regularMarketDayHigh": 1.95, "regularMarketDayRange": "1.748 - 1.95", "regularMarketDayLow": 1.748, "regularMarketVolume": 88587, "regularMarketPreviousClose": 1.942, "bid": 1.764, "ask": 1.834, "bidSize": 0, "askSize": 0, "fullExchangeName": "Oslo", "regularMarketChangePercent": -5.6642647, "regularMarketPrice": 1.832, "exchangeTimezoneName": "Europe/Oslo", "exchangeTimezoneShortName": "CEST", "gmtOffSetMilliseconds": 7200000, "esgPopulated": false, "exchange": "OSL", "shortName": "BERGENBIO", "longName": "BerGenBio ASA", "messageBoardId": "finmb_107144331", "market": "no_market", "symbol": "BGBIO.OL"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "M\u00f8llendalsbakken 9", "city": "Bergen", "zip": "5009", "country": "Norway", "phone": "47 53 50 15 64", "website": "https://www.bergenbio.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "BerGenBio ASA, a clinical-stage biopharmaceutical company, engages in development of drugs to treat immune evasive, drug resistant, and metastatic cancers; and respiratory diseases. Its lead candidate is Bemcentinib, an oral once-a-day inhibitor of AXL receptor tyrosine kinase, which is in Phase II clinical development that focuses on treatment of non-small cell lung cancer, acute myeloid leukaemia, and COVID-1. The company is also developing tilvestamab, an anti-AXL function-blocking monoclonal antibody that is in Phase Ib clinical trial. It has a collaboration agreement with Merck & Co. for clinical trials. The company was incorporated in 2007 and is based in Bergen, Norway.", "fullTimeEmployees": 29, "companyOfficers": [{"maxAge": 1, "name": "Mr. Martin  Olin", "age": 53, "title": "Chief Exec. Officer", "yearBorn": 1969, "fiscalYear": 2022, "totalPay": {"raw": 867765, "fmt": "867.76k", "longFmt": "867,765"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Rune  Skeie", "age": 49, "title": "Chief Financial Officer", "yearBorn": 1973, "fiscalYear": 2022, "totalPay": {"raw": 2559000, "fmt": "2.56M", "longFmt": "2,559,000"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. James  Barnes Ph.D.", "title": "Chief Operating Officer", "fiscalYear": 2022, "totalPay": {"raw": 269000, "fmt": "269k", "longFmt": "269,000"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Nigel  McCracken M.Sc., Ph.D.", "title": "Chief Scientific Officer", "fiscalYear": 2022, "totalPay": {"raw": 374745, "fmt": "374.75k", "longFmt": "374,745"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Gayle M. Mills M.B.A", "age": 67, "title": "Chief Bus. Officer", "yearBorn": 1955, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Cristina  Oliva M.D.", "title": "Chief Medical Officer", "fiscalYear": 2022, "totalPay": {"raw": 342507, "fmt": "342.51k", "longFmt": "342,507"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Graham  Morell", "title": "Head of IR", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Akil  Jackson", "title": "Medical Director", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}